OrganiGram Holdings Financials
OGI Stock | USD 1.51 0.01 0.67% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 4.0E-4 | 5.0E-4 |
|
| |||||
Current Ratio | 5.85 | 4.0087 |
|
|
The essential information of the day-to-day investment outlook for OrganiGram Holdings includes many different criteria found on its balance sheet. An individual investor should monitor OrganiGram Holdings' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in OrganiGram Holdings.
Net Income |
|
OrganiGram | Select Account or Indicator |
Understanding current and past OrganiGram Holdings Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of OrganiGram Holdings' financial statements are interrelated, with each one affecting the others. For example, an increase in OrganiGram Holdings' assets may result in an increase in income on the income statement.
OrganiGram Holdings Stock Summary
OrganiGram Holdings competes with Haleon Plc, and Intracellular. Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada. Organigram Hlds is traded on NASDAQ Exchange in the United States.Foreign Associate | Canada |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | CA68620P1018 |
CUSIP | 68620P101 68620P705 |
Location | New Brunswick; Canada |
Business Address | 145 King Street |
Sector | Pharmaceuticals |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.organigram.ca |
Phone | 855 961 9420 |
Currency | USD - US Dollar |
OrganiGram Holdings Key Financial Ratios
Return On Equity | -0.55 | ||||
Profit Margin | (1.54) % | ||||
Operating Margin | (0.12) % | ||||
Price To Sales | 1.10 X | ||||
Revenue | 149.21 M |
OrganiGram Holdings Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 417.6M | 554.0M | 577.1M | 298.5M | 343.2M | 251.2M | |
Other Current Liab | (11.6M) | 6.3M | 12.0M | 2.3M | 2.6M | 2.1M | |
Net Debt | 79.1M | (50.4M) | (65.2M) | (30.2M) | (27.1M) | (25.8M) | |
Retained Earnings | (144.9M) | (275.6M) | (289.9M) | (538.5M) | (484.7M) | (460.4M) | |
Cash | 24.6M | 55.4M | 68.5M | 33.9M | 38.9M | 27.4M | |
Net Receivables | 17.0M | 21.0M | 43.9M | 27.5M | 31.6M | 33.2M | |
Total Liab | 118.1M | 74.2M | 69.0M | 26.8M | 30.9M | 48.9M | |
Total Current Assets | 170.2M | 260.6M | 221.6M | 156.0M | 179.4M | 119.0M | |
Accounts Payable | 17.5M | 19.0M | 40.9M | 20.0M | 23.0M | 15.8M | |
Common Stock | 420.7M | 730.8M | 769.7M | 776.9M | 893.4M | 938.1M | |
Other Liab | 231K | 43.1M | 11.4M | 771K | 886.7K | 842.3K | |
Net Tangible Assets | 297.8M | 462.8M | 451.8M | 261.0M | 300.1M | 258.4M | |
Other Assets | 8.7M | 35.4M | 33.1M | 1.0 | 1.15 | 1.09 | |
Long Term Debt | 46.1M | 103.7M | 230K | 155K | 178.3K | 169.3K | |
Inventory | 71.8M | 48.8M | 68.3M | 81.0M | 93.1M | 56.5M | |
Other Current Assets | 6.7M | 7.0M | 10.6M | 13.7M | 15.8M | 10.0M | |
Short Long Term Debt | 421K | 3.5M | 11.6M | 80K | 92K | 87.4K | |
Short Term Debt | 11.6M | 1.1M | 996K | 76K | 87.4K | 83.0K | |
Intangible Assets | 1.8M | 2.7M | 14.3M | 10.6M | 12.2M | 12.8M |
OrganiGram Holdings Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 6.0M | 3.0M | 429K | 277.8K | 319.5K | 303.5K | |
Operating Income | (145.5M) | (91.8M) | (38.8M) | (48.8M) | (43.9M) | (41.7M) | |
Ebit | (140.6M) | (74.0M) | (40.1M) | (48.8M) | (43.9M) | (41.7M) | |
Ebitda | (122.7M) | (42.9M) | (15.2M) | (25.4M) | (22.8M) | (21.7M) | |
Income Before Tax | (146.6M) | (130.7M) | (14.4M) | (233.0M) | (209.7M) | (199.2M) | |
Net Income | (136.2M) | (132.5M) | (14.3M) | (229.5M) | (206.5M) | (196.2M) | |
Income Tax Expense | (10.5M) | 1.8M | (88K) | 3.5M | 4.0M | 4.2M | |
Total Revenue | 86.8M | 79.2M | 145.8M | 149.2M | 171.6M | 180.2M | |
Gross Profit | (56.5M) | (28.4M) | 31.6M | 35.1M | 40.3M | 42.4M | |
Cost Of Revenue | 143.3M | 107.6M | 114.2M | 114.1M | 131.3M | 137.8M | |
Research Development | 1.3M | 3.5M | 6.0M | 12.2M | 14.0M | 14.7M | |
Net Interest Income | (9.7M) | (6.0M) | (3.0M) | (429K) | (386.1K) | (405.4K) | |
Tax Provision | 3.6M | (10.5M) | 0.0 | (88K) | (79.2K) | (83.2K) |
OrganiGram Holdings Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (23.0M) | 30.8M | 13.2M | (68.5M) | (61.7M) | (58.6M) | |
Free Cash Flow | (123.8M) | (40.9M) | (85.0M) | (62.7M) | (56.4M) | (59.2M) | |
Capital Expenditures | 78.7M | 12.3M | 48.8M | 26.9M | 30.9M | 34.8M | |
Net Income | (136.2M) | (130.7M) | (14.3M) | (229.5M) | (206.5M) | (196.2M) | |
End Period Cash Flow | 24.6M | 55.4M | 68.5M | 33.9M | 38.9M | 27.4M | |
Change To Inventory | (40.9M) | 45.6M | 28.7M | (12.2M) | (14.1M) | (13.3M) | |
Depreciation | 18.0M | 31.0M | 24.9M | 24.1M | 27.7M | 29.1M | |
Other Non Cash Items | 46.7M | 776K | (29.0M) | 151.8M | 174.6M | 183.3M | |
Investments | (138.2M) | (72.5M) | 95.5M | 20.1M | 23.2M | 24.3M | |
Net Borrowings | 64.0M | (116.4M) | (1.0M) | (772.6K) | (695.4K) | (660.6K) | |
Change To Netincome | 44.0M | 46.1M | (24.0M) | 174.6M | 200.8M | 210.8M |
OrganiGram Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining OrganiGram Holdings's current stock value. Our valuation model uses many indicators to compare OrganiGram Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OrganiGram Holdings competition to find correlations between indicators driving OrganiGram Holdings's intrinsic value. More Info.OrganiGram Holdings is regarded third in return on equity category among its peers. It is regarded second in return on asset category among its peers . As of now, OrganiGram Holdings' Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OrganiGram Holdings' earnings, one of the primary drivers of an investment's value.OrganiGram Holdings Systematic Risk
OrganiGram Holdings' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. OrganiGram Holdings volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on OrganiGram Holdings correlated with the market. If Beta is less than 0 OrganiGram Holdings generally moves in the opposite direction as compared to the market. If OrganiGram Holdings Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one OrganiGram Holdings is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of OrganiGram Holdings is generally in the same direction as the market. If Beta > 1 OrganiGram Holdings moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in OrganiGram Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various OrganiGram Holdings' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of OrganiGram Holdings growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
OrganiGram Holdings November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of OrganiGram Holdings help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of OrganiGram Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of OrganiGram Holdings based on widely used predictive technical indicators. In general, we focus on analyzing OrganiGram Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build OrganiGram Holdings's daily price indicators and compare them against related drivers.
Information Ratio | (0.14) | |||
Maximum Drawdown | 14.87 | |||
Value At Risk | (4.24) | |||
Potential Upside | 3.95 |
Complementary Tools for OrganiGram Stock analysis
When running OrganiGram Holdings' price analysis, check to measure OrganiGram Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OrganiGram Holdings is operating at the current time. Most of OrganiGram Holdings' value examination focuses on studying past and present price action to predict the probability of OrganiGram Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OrganiGram Holdings' price. Additionally, you may evaluate how the addition of OrganiGram Holdings to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |